<SEC-DOCUMENT>9999999997-14-015711-index.html : 20141209
<SEC-HEADER>9999999997-14-015711.hdr.sgml : 20141209
<ACCEPTANCE-DATETIME>20141209094945
ACCESSION NUMBER:		9999999997-14-015711
CONFORMED SUBMISSION TYPE:	CT ORDER
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20141209
DATE AS OF CHANGE:		20141209
<ACTION-DATE>20141209
<RECEIVED-DATE>20141209

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NAVIDEA BIOPHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0000810509
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				311080091
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CT ORDER
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35076
		FILM NUMBER:		141274001

	BUSINESS ADDRESS:	
		STREET 1:		5600 BLAZER PARKWAY
		STREET 2:		SUITE 200
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017
		BUSINESS PHONE:		6147937500

	MAIL ADDRESS:	
		STREET 1:		5600 BLAZER PARKWAY
		STREET 2:		SUITE 200
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NEOPROBE CORP
		DATE OF NAME CHANGE:	19940714
</SEC-HEADER>
<DOCUMENT>
<TYPE>CT ORDER
<SEQUENCE>1
<FILENAME>filename1.pdf
<TEXT>
Document 1 - file: filename1.pdf

</DOCUMENT>
</SEC-DOCUMENT>